RARE - Ultragenyx Pharmaceutical Inc.
IEX Last Trade
43.775
0.215 0.491%
Share volume: 23,733
Last Updated: Fri 27 Dec 2024 02:30:11 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
0.33%
PREVIOUS CLOSE
CHG
CHG%
$43.56
0.22
0.49%
Summary score
8%
Profitability
0%
Dept financing
21%
Liquidity
53%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-68.46%
Return on assets
-8.78%
Return on sales
-130.34%
Return on invested capital
-33.72%
Total debt ratio
61.45%
Debt ratio change over timeo
-2.68%
Current Ratio
4.41%
Quick Ratio
4.3%
Cash Position Ratio
3.58%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-175.06%
Return on assets
-9.94%
Return on sales
-118.71%
Return on invested capital
-34.61%
Total debt ratio
85.38%
Debt ratio change over timeo
-3.54%
Current Ratio
2.73%
Quick Ratio
2.6%
Cash Position Ratio
2.07%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
-30.43%
Return on assets
-7.19%
Return on sales
-79.14%
Return on invested capital
-34.55%
Total debt ratio
73.28%
Debt ratio change over time
-3.12%
Current Ratio
3.54%
Quick Ratio
3.39%
Cash Position Ratio
2.8%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
76.03%
Return on assets
-73.65%
Return on sales
306.78%
Return on invested capital
-21.86%
Total debt ratio
-268.1%
Debt ratio change over time
-2.68%
Current Ratio
-16.28%
Quick Ratio
-15.95%
Cash Position Ratio
-15.58%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | RARE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -68.46% | 15.05% | 35.64% | 7.13% |
| Return on assets | -8.78% | 2.88% | 3.13% | 5.53% |
| Return on sales | -130.34% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | -33.72% | 2.57% | 5.37% | 18.48% |
| Profitability | 0% | 45% | 66% | 80% |
| Total debt ratio | 61.45% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | -2.68% | 326.95% | -8.44% | 1.18% |
| Dept financing | 17% | 50% | 25% | 7% |
| Current Ratio | 2.73% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 2.6% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 2.07% | 0.39% | 1.05% | 2.91% |
| Liquididy | 74% | 12% | 26% | 63% |
| Short-term ratios | RARE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -175.06% | 13.14% | 10.88% | 4.07% |
| Return on assets | -9.94% | 2.1% | 1.54% | 3.03% |
| Return on sales | -118.71% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | -34.61% | 1.95% | 2.74% | 9.55% |
| Profitability | 0% | 65% | 56% | 83% |
| Total debt ratio | 85.38% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | -3.54% | 51.04% | -101.54% | 1.43% |
| Dept financing | 23% | 50% | 25% | 7% |
| Current Ratio | 2.73% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 2.6% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 2.07% | 0.39% | 1.05% | 2.91% |
| Liquididy | 44% | 12% | 27% | 75% |